Co-Diagnostics, Inc. Skyrocketed
Thu, Feb 27, 2020 at 05:30 PM
Co-Diagnostics, Inc. (CODX:NASDAQ) shot up at $15.96, representing a gain of 79.3%. On Wed 26 Feb 20, CODX:NASDAQ hit a New 2-Week High of $8.9. The stock got featured on our News Catalysts scanner on Tue 25 Feb 20 at 08:15 PM in the 'MISCELLANEOUS' category. From Wed 05 Feb 20, the stock recorded 57.14% Up Days and 60.00% Green Days
About Co-Diagnostics, Inc. (CODX:NASDAQ)
Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
Top 10 Gainers:
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 321.74%
- iBio, Inc. (IBIO:NYSEMKT), 158.98%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 103.79%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 92.22%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 79.33%
- Vir Biotechnology, Inc. (VIR:NASDAQ), 72.12%
- GAIN Capital Holdings, Inc. (GCAP:NYSE), 66.01%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 58.73%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 54.05%
- Vaxart, Inc. (VXRT:NASDAQ), 49.7%